Languita, Gelmar O.

HRN: 24-08-69  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2023
CEFUROXIME 1.5GM (VIAL)
11/16/2023
11/23/2023
IV
1.5grams
Q8H
Soft Tissue Injuries Sec To MVA; T/c TBI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: